Atellica CH Diazo Total Bilirubin (D_TBil)
Diazo Colorimetry, Bilirubin. 510(k) K251998, from Siemens Healthcare Diagnostics, Inc. (Newark, DE). Product code CIG, class 2.
As of Nov 17, 2026, K251998 is an FDA 510(k) held by Siemens Healthcare Diagnostics, Inc., substantially equivalent on Feb 27, 2026 after 245 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Feb 27, 2026
- Review time: 245 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Atellica CH Diazo Total Bilirubin (D_TBil) assay is for in vitro diagnostic use in the quantitative determination of total bilirubin in human serum and plasma of adults and neonates using the Atellica CH Analyzer.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Cobas C Bilirubin Total GEN.3K131544 · Roche Diagnostics · Jul 17, 2013
Other CIG Clearances
The newest 510(k)s for the same product code; their median review was 245 days; see every CIG device- Atellica® CH Diazo Direct Bilirubin (D_DBil)K223078 · Siemens Healthcare Diagnostics, Inc. · Jun 12, 2023
- Atellica® CH Diazo Total Bilirubin (D_TBil)K222104 · Siemens Healthcare Diagnostics, Inc. · Mar 20, 2023
- Total Bilirubin2K223324 · Abbott Ireland Diagnostics Division · Dec 29, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 27, 2025
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1110
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files